ebook Munafa Stock Market Course + Intraday & FNO calls  

       

SLS announcements Sellas Life Sciences Group, Inc. announcements and dividends declared NASDAQ

Sellas Life Sciences Group, Inc. Complete list of announcements declared & dividend announcements by Sellas Life Sciences Group, Inc. SLS

Sellas Life Sciences Group, Inc. SLS listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Sellas Life Sciences Group, Inc. SLS

SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised)
SELLAS Life Sciences Group (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Announcement as on 31 July 2025

Cantor Fitzgerald Reiterates SELLAS Life Sciences Group (SLS) Overweight Recommendation
Fintel reports that on September 7, 2023, Cantor Fitzgerald reiterated coverage of SELLAS Life Sciences Group (NASDAQ:SLS) with a Overweight recommendation.
Announcement as on 08 September 2023

: Sellas Life Sciences raises million from public offering of stock, warrants
Sellas Life Sciences Group Inc. SLS said Friday that it raised .0 million, through the public sale of common shares and warrants to buy stock. Shares of the biopharmaceutical company, which is focused on cancer treatments, plummeted 43.1% in premarket t
Announcement as on 24 February 2023

SELLAS Life Sciences Inks License Deal With GenFleet Therapeutics For CDK9 Inhibitor; Stock Down
(RTTNews) - SELLAS Life Sciences Group, Inc. (SLS), late-stage clinical biopharmaceutical company focused on development of cancer therapies, announced it has entered into an exclusive license agreement with GenFleet Therapeutics (Shanghai), Inc. that gran
Announcement as on 31 March 2022

Announcements by Sellas Life Sciences Group, Inc. first page |

SLS Sellas Life Sciences Group, Inc. current price & indicator signals

Moving Averages for Sellas Life Sciences Group, Inc.

  • 5Day Average: 1.58
  • 12Day Average: 1.54
  • 20Day Average: 1.52
  • 50Day Average: 1.75
  • 100Day Average: 1.75
  • 150Day Average: 1.76
  • 200Day Average: 1.62

SLS Indicators & signals

Indicator MACD (12,26,9)

1.58, 1.62, -0.09
Indicator MACD is in negative zone

Indicator ADX (14)

12.5, 56.25, 43.75
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SLS Sellas Life Sciences Group, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 1.75 1.69 to 1.86 0.57% 1.04 times
04 Thu Dec 2025 1.74 1.52 to 1.84 12.99% 2.65 times
03 Wed Dec 2025 1.54 1.41 to 1.55 10.79% 0.97 times
02 Tue Dec 2025 1.39 1.39 to 1.55 -7.33% 1.21 times
01 Mon Dec 2025 1.50 1.50 to 1.60 -7.41% 0.71 times
28 Fri Nov 2025 1.62 1.47 to 1.64 11.72% 0.57 times
26 Wed Nov 2025 1.45 1.42 to 1.50 0.69% 0.94 times
25 Tue Nov 2025 1.44 1.43 to 1.59 -7.69% 0.9 times
24 Mon Nov 2025 1.56 1.51 to 1.61 1.96% 0.71 times
21 Fri Nov 2025 1.53 1.50 to 1.56 4.79% 0.79 times
20 Thu Nov 2025 1.46 1.45 to 1.61 -3.95% 0.54 times
19 Wed Nov 2025 1.52 1.52 to 1.63 -4.4% 0.71 times

Videos related to: SLS announcements Sellas Life Sciences Group, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

SLS announcements Sellas Life Sciences Group, Inc. announcements and dividends declared NASDAQ

 

Back to top